As clinical diagnostics become a central force in shaping therapies and driving innovation, healthcare leaders must prepare ...
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a pioneering certified biotechnology ...
Updated guidance on vascular cognitive impairment emphasizes executive function and processing speed, endorses brief, ...
With the rise of biologics, precision medicine and AI-driven drug discovery, clinical research has entered a new and complex ...
Rheumatoid arthritis is a painful, progressive joint disease characterized by particularly acute flare-ups. Biologics, used to treat autoimmune diseases such as rheumatoid arthritis, target symptom ...
Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...
The PanCAN Patient Services team is here for patients and their loved ones as they navigate clinical trials. Our Case Managers offer personal, one-to-one support at every step of the search and ...
ASHBURN, Va., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (QNRX), a clinical-stage specialty pharmaceutical company focused on novel treatments for rare and orphan diseases, today ...
SAN FRANCISCO, CA, UNITED STATES, January 6, 2026 /EINPresswire.com/ — Rising Star Optometry continues to expand its clinical ...
Kymera Therapeutics has announced that Sanofi will advance their next-generation oral IRAK4 degrader, KT-485, into clinical testing, while opting not to pursue KT-474. Preclinical studies indicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback